FDA's reviews of new drugs : changes needed in process for reviewing and reporting on clinical studies : report to the ranking minority member, Special Committee on Aging, U.S. Senate / United States General Accounting Office
資料に関する注記
一般注記:
この資料の詳細や典拠(同じ主題の資料を指すキーワード、著者名)等を確認できます。